Pediatric Device Consortia (PDC) Grants Program

The Pediatric Device Consortia Grants Program is the FDA Office of Orphan Products Development's route for building nonprofit consortia that help pediatric medical device development move forward. Reauthorized for fiscal years 2023 through 2027 by FDORA 2022, it funds shared infrastructure that gives pediatric device innovators access to regulatory, business, and device-development support. The consortia offer practical services such as intellectual property advising, prototyping, engineering, laboratory testing, grant-writing, and direct project funding to innovators. Annual funding is about $6 million, and FDA funded five consortia nationwide in FY2023. Eligibility is limited to nonprofit consortia; for-profits are not eligible, universities and research organizations may participate, and the consortium must be based in the United States. The current sources do not confirm a next RFA date. This program is designed for applicants that can act as a shared platform rather than a single product sponsor. It suits groups that can support a pipeline of pediatric device projects, connect innovators to specialized expertise, and turn modest federal support into broader developmental leverage. The strongest proposals are likely to show that the consortium can serve multiple projects, not just a narrow internal agenda, and can help children's devices move through the early technical and regulatory hurdles that often slow the field.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.